Mark W Frohlich
CIK 1420482 · See Remarks · last filed 2026-05-19
Mark W Frohlich is a corporate insider who has filed 57 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for RIGL, was dated May 19, 2026. Across all open-market trades the lifetime net is −$705.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $229.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$229.9K
2
57
-$705.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RIGL | Director | 7,000 | $32.85 | $229.9K | $0 | 3 | 2026-05-19 |
| Juno Therapeutics, Inc. (JUNO) Delisted | See Remarks | 919,583 | — | — | -$705.3K | 3 | 2016-03-02 |
Recent Filings
57 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-19 | RIGL | Grant (A) | +5,750 | $0 | EDGAR |
| 2025-05-28 | RIGL | Grant (A) | +1,250 | $0 | EDGAR |
| 2025-03-10 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2016-03-02 | Juno Therapeutics, Inc. (JUNO) Delisted | Sell (S) | −20,000 | -$705.3K | EDGAR |
| 2016-02-04 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-05 | Juno Therapeutics, Inc. (JUNO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-01-22 | — | Tax (F) | −888 | -$2.8K | |
| 2014-01-07 | — | Mixed | −10,773 | -$33.2K | |
| 2013-10-22 | — | Tax (F) | −743 | -$1.8K | |
| 2013-10-04 | — | Tax (F) | −2,564 | -$7.2K |